Michigan Medicine Expands System-Wide COVID-19 Vaccination Eligibility

ANN ARBOR – Michigan Medicine announced in an email to staff on Monday that it has expanded the priority group for the Phase 1A COVID-19 vaccine after administering more than 11,000 vaccines since Dec. 14.

Based on the state’s recommendations, those now eligible for a Phase 1A vaccine at the University of Michigan include:

• Anyone working at Michigan Medicine or the University of Michigan who works in a clinical setting (hospital, outpatient clinic, home care) and cannot work exclusively remotely can now receive a COVID-19 vaccine as part of phase 1A.
• Anyone in a position at the University of Michigan in a clinical setting who cannot work exclusively remotely can also receive a COVID-19 vaccine as part of Phase 1A. This includes staff and students working in the following fields: academic health services, dentistry, nursing, social work, kinesiology, public health, pharmacy and others who work in a clinical environment.

“There will be enough vaccines for everyone and we expect new shipments every week,” the email read.

Michigan Medicine reported the following vaccine data at 9 a.m. on Monday:

• Number of total vaccine doses received by the University of Michigan: 11,950
• Number of vaccines administered to the UM community: 10,900
• Number of vaccines administered to the UM community on Sunday January 3: 870
• Number of appointments for vaccines currently scheduled for Monday January 4 and Tuesday January 5: 1,594

With a new vaccine delivery expected on Tuesday, Michigan Medicine estimates it will schedule the last of its current Phase 1A group until January 12.

Michigan Medicine administers vaccines seven days a week. Michigan Stadium opened on Thursday as a new vaccination site, which will play a central role in inoculating tens of thousands of people as the healthcare system receives more doses of the vaccine.

Related reading: